novo nordisk semaglutide weight loss Sinks on Disappointing Trial Results for Next Gen Drug Novo Nordisk and Hims &

Addressing Employee Demand and Workforce Expectations Employee interest in GLP-1 medications continues to increase as awareness grows and obesity rates rise nationwide

19 This showed a treatment difference of 0.0% in mean change in HbA1c from baseline, and that albiglutide 50 mg was non-inferior to exenatide 2.0 mg QW at the non-inferiority margin of 0.3%

FACS analysis confirmed that at passage 10, 54.7% of EpCAM+ HBs co-expressed the proliferative marker Ki67, and immunostaining showed sustained co-expression of AFP, HNF4, and Ki67

For Tirzepatide and Retatrutide, PK studies reveal their long half-lives

To access Antiviral Drugs Market to Reach USD 127 Billion by 2035, Growing at 6.1% CAGR | The global antiviral drugs market, valued at USD 69 billion in 2025, will reach USD 74 billion in 2026 and climb to USD 127 billion by 2035, advancing at a CAGR of 6.1% over the forecast period